Zilico, a British medical device manufacturer, will present its CE marked cervical cancer diagnostic system at the upcoming Arab Health 2014.

ZedScan system, which received EC certification from its notified body in September last year, offers more accurate detection of cervical neoplasia in real-time, enabling clinicians to improve patient management, said a statement.

Commercial director Chris Harris will present the system at the four-day exhibition, which will take place at the Dubai International Convention and Exhibition Centre from January 27.

The ZedScan system is used alongside colposcopy on women identified with an abnormal smear result, said the statement.

It helps identify those patients who require treatment at first visit, facilitating a wider use of “select and treat,” in addition to reducing the number of cervical biopsies performed on each patient by pin-pointing the optimum site for biopsy.

The company’s patented Electrical Impedance Spectroscopy (EIS) technology exploits the different electrical resistivity of normal, pre-cancerous and cancerous tissue.

The system consists of a portable hand-held device and docking station, software application and a single-use EIS sensor.

Sameer Kothari, chief executive, said: “ZedScan has generated substantial interest from distributors across the globe through various presentations, conferences and clinical meetings and we now look forward to being able to satisfy the growing demand in healthcare markets across the Middle East.” - TradeArabia News Service